Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.57
(0.0%)
CNY 3.57
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.34 Billion CNY | 25.26% |
| 2022 | 1.2 Billion CNY | 14.05% |
| 2021 | 1.05 Billion CNY | 44.6% |
| 2020 | 730.61 Million CNY | 41.02% |
| 2019 | 518.08 Million CNY | -22.11% |
| 2018 | 665.11 Million CNY | -7.8% |
| 2017 | 721.41 Million CNY | -0.36% |
| 2016 | 724.04 Million CNY | 7.46% |
| 2015 | 673.75 Million CNY | 7.92% |
| 2014 | 624.3 Million CNY | 51.34% |
| 2013 | 412.52 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 299.73 Million CNY | -72.44% |
| 2024 Q3 | 303.33 Million CNY | 37.57% |
| 2024 Q2 | 282.99 Million CNY | -5.58% |
| 2023 Q4 | 1.08 Billion CNY | 320.86% |
| 2023 FY | 1.5 Billion CNY | 25.26% |
| 2023 Q1 | 274.29 Million CNY | -16.25% |
| 2023 Q2 | 285.7 Million CNY | 4.16% |
| 2023 Q3 | 258.42 Million CNY | -9.55% |
| 2022 Q1 | 266.67 Million CNY | -19.22% |
| 2022 FY | 1.2 Billion CNY | 14.05% |
| 2022 Q3 | 330.7 Million CNY | 18.12% |
| 2022 Q4 | 327.5 Million CNY | -0.97% |
| 2022 Q2 | 279.97 Million CNY | 4.99% |
| 2021 Q3 | 230.04 Million CNY | -10.98% |
| 2021 Q4 | 330.13 Million CNY | 43.51% |
| 2021 Q1 | 237.84 Million CNY | -6.78% |
| 2021 Q2 | 258.41 Million CNY | 8.65% |
| 2021 FY | 1.05 Billion CNY | 44.6% |
| 2020 Q4 | 255.12 Million CNY | 37.43% |
| 2020 Q2 | 160.95 Million CNY | 24.88% |
| 2020 FY | 730.61 Million CNY | 41.02% |
| 2020 Q1 | 128.88 Million CNY | -4.46% |
| 2020 Q3 | 185.64 Million CNY | 15.34% |
| 2019 FY | 518.08 Million CNY | -22.11% |
| 2019 Q4 | 134.9 Million CNY | 23.2% |
| 2019 Q3 | 109.5 Million CNY | -17.36% |
| 2019 Q2 | 132.5 Million CNY | -6.15% |
| 2019 Q1 | 141.18 Million CNY | -15.09% |
| 2018 Q2 | 160.06 Million CNY | -4.89% |
| 2018 Q4 | 166.27 Million CNY | -2.46% |
| 2018 Q3 | 170.47 Million CNY | 6.5% |
| 2018 FY | 665.11 Million CNY | -7.8% |
| 2018 Q1 | 168.29 Million CNY | -13.99% |
| 2017 FY | 721.41 Million CNY | -0.36% |
| 2017 Q1 | 173.1 Million CNY | -10.74% |
| 2017 Q2 | 174.68 Million CNY | 0.92% |
| 2017 Q3 | 177.94 Million CNY | 1.86% |
| 2017 Q4 | 195.67 Million CNY | 9.97% |
| 2016 Q4 | 193.92 Million CNY | 7.46% |
| 2016 FY | 724.04 Million CNY | 7.46% |
| 2016 Q3 | 180.46 Million CNY | 0.0% |
| 2015 FY | 673.75 Million CNY | 7.92% |
| 2014 FY | 624.3 Million CNY | 51.34% |
| 2013 FY | 412.52 Million CNY | 0.0% |